Radiotherapy of classic and human immunodeficiency virus-related Kaposi's sarcoma: results in 1482 lesions
Corresponding Author
M Caccialanza
Department of Photoradiotherapy, Institute of Dermatological Sciences of the University, Milan, Italy
*Corresponding author, Department of Photoradiotherapy, Institute of Dermatological Sciences of the University, Via Pace 9, 20122 Milan, Italy, tel. +39 02 55035303; fax +39 02 55035256; E-mail: [email protected]Search for more papers by this authorS Marca
Department of Photoradiotherapy, Institute of Dermatological Sciences of the University, Milan, Italy
Search for more papers by this authorR Piccinno
Department of Photoradiotherapy, Institute of Dermatological Sciences of the University, Milan, Italy
Search for more papers by this authorG Eulisse
Department of Health Physics, Fondazione Ospedale Maggiore, Mangiagalli e Regina Elena, IRCCS, Milan, Italy
Search for more papers by this authorCorresponding Author
M Caccialanza
Department of Photoradiotherapy, Institute of Dermatological Sciences of the University, Milan, Italy
*Corresponding author, Department of Photoradiotherapy, Institute of Dermatological Sciences of the University, Via Pace 9, 20122 Milan, Italy, tel. +39 02 55035303; fax +39 02 55035256; E-mail: [email protected]Search for more papers by this authorS Marca
Department of Photoradiotherapy, Institute of Dermatological Sciences of the University, Milan, Italy
Search for more papers by this authorR Piccinno
Department of Photoradiotherapy, Institute of Dermatological Sciences of the University, Milan, Italy
Search for more papers by this authorG Eulisse
Department of Health Physics, Fondazione Ospedale Maggiore, Mangiagalli e Regina Elena, IRCCS, Milan, Italy
Search for more papers by this authorAbstract
Background The lesions of the various forms of Kaposi's sarcoma (KS), which are relatively radiosensitive, have been treated with different modalities of radiotherapy, with heterogeneous aims and results.
Objective To verify the effectiveness and safety of radiotherapy on a large number of lesions endowed (classic KS) with a prolonged follow-up.
Methods A retrospective study was done on 711 lesions of classic KS and 771 lesions of human immunodeficiency virus (HIV)-related KS, treated with traditional X-ray therapy.
Results In classic KS, a cure rate of 98.7% resulted after 13.5 years from the end of radiotherapy. In three lesions (0.42%) in the same patient, an acute radiodermatitis occurred after traumatic action. In HIV-related KS, a complete remission was obtained in 91.43% of the lesions, partial remission in 6.74% and non-response in 0.51% at 1 to 46 months from the end of radiotherapy.
Conclusion Radiotherapy showed to be a safe and effective method, with relevant importance in the therapeutic strategy of KS.
References
- 1
Kaposi M.
Idiopathic multiple pigmented sarcoma of the skin.
Arch Dermatol Syphil
1872; 4: 265–273.
10.1007/BF01830024 Google Scholar
- 2 Centers for Disease Control and Prevention. Kaposi's sarcoma and Pneumocystis pneumonia among homosexual men – New York City and California. Morb Mortal Wkly Rep 1981; 30: 305–308.
- 3 Ensoli B, Sgadari C, Barillari G, Sirianni MC, Stürzl M, Monini P. Biology of Kaposi's sarcoma. Eur J Cancer 2001; 37: 1251–1269.
- 4
Cooper JS.
Staging of skin tumors: a mirror of their biologic behaviour. In: RG Panizzon,
JS Cooper, eds. Radiation Treatment and Radiation Reactions in Dermatology. Chapter 7. Springer Verlag, Heidelberg, Berlin, New York, 2004: 63–67.
10.1007/978-3-642-18830-5_7 Google Scholar
- 5 Mitsuyasu RT. Clinical variants and staging of Kaposi's sarcoma. Semin Oncol 1987; 14 (Suppl): 13–18.
- 6 Caccialanza M. Radiotherapy of neoplastic lesions of the eyelid. Ital Gen Rev Dermatol 1989; 26: 221–225.
- 7 Caccialanza M, Piccinno R, Gnecchi L, Beretta M, Cusini M. Intracavitary contact x-ray therapy of oral HIV-associated Kaposi's sarcoma. Int J STD AIDS 1997; 8: 581–584.
- 8 Caccialanza M. Radiotherapy for Kaposi's Sarcoma. Ital Gen Rev Dermatol 1989; 26: 242–246.
- 9 Piccinno R, Caccialanza M, Cusini M. Role of radiotherapy in the treatment of epidemic Kaposi's sarcoma: experience with sixty-five cases. J Am Acad Dermatol 1995; 32: 1000–1003.
- 10 Lo TC, Salzman FA, Smedal MI, Wright KA. Radiotherapy for Kaposi's sarcoma. Cancer 1980; 45: 694–687.
- 11 Tur E, Brenner S. Treatment of Kaposi's sarcoma. Arch Dermatol 1996; 132: 327–331.
- 12 Fenig E, Brenner B, Rakowsky E, Lapidoth M, Katz A, Sulkes A. Classic Kaposi sarcoma: experience at Rabin Medical Center in Israel. Am J Clin Oncol 1998; 21: 498–500.
- 13 Kirova YM, Belembaogo E, Frikha H et al . Radiotherapy in the management of epidemic Kaposi's sarcoma: a retrospective study on 643 cases. Radiother Oncol 1998; 46: 19–22.
- 14 Piedbois P, Frikha H, Martin L, Levy E, Haddad E, Le Bourgeois JP. Radiotherapy in the management of epidemic Kaposi's sarcoma. Int J Radiat Oncol Biol Phys 1994; 30: 1207–1211.
- 15 Guillot B, Carles MJ, Foulongne V, Dereure O, Ramuz M. Lack of modification of immunological status after chemotherapy or radiotherapy for classic Kaposi's sarcoma (letter). Br J Dermatol 2002; 146: 337–338.
- 16 Cooper JS, Sacco J, Newall J. The duration of local control of classic (non-AIDS associated) Kaposi's sarcoma by radiotherapy. J Am Acad Dermatol 1988; 19: 59–66.
- 17 Lukawska J, Cottrill C, Bower M. The changing role of radiotherapy in AIDS-related malignancies. Clin Oncol (R Coll Radiol) 2003; 15: 2–6.
- 18 Le Bourgeois JP, Frikha H, Piedbois P, Le Péchoux C, Martin L, Haddad E. Radiotherapy in the management of epidemic Kaposi's sarcoma of the oral cavity, the eyelid and the genitals. Radiother Oncol 1994; 30: 263–266.
- 19 Watkins EB, Findlay P, Gelmann E, Lane HC, Zabell A. Enhanced mucosal reactions in AIDS patients receiving oropharingeal irradiation. Int J Radiat Oncol Biol Phys 1987; 13: 1403–1408.
- 20 Hughes-Davis L, Young T, Spittle M. Radiosensitivity in AIDS patients (letter). Lancet 1991; 337: 1616.
- 21 Tappero JW, Berger TG, Kaplan LD, Volberding PA, Kahn JO. Cryotherapy for cutaneous Kaposi's sarcoma (KS) associated with immunodeficiency syndrome (AIDS): a phase II trial. J Acquir Immune Defic Syndr 1991; 4: 839–846.
- 22 Marchell N, Alster TS. Successful treatment of cutaneous Kaposi's sarcoma by the 585 nm pulsed dye laser. Dermatol Surg 1997; 23: 973–995.
- 23 Chun YS, Chang SN, Park WH. A case of classical Kaposi's sarcoma of the penis showing a good response to high–energy pulsed carbon dioxide laser therapy. J Dermatol 1999; 26: 240–243.
- 24 Tappero JW, Grekin RC, Zanelli GA, Berger TG. Pulsed-dye laser therapy for cutaneous Kaposi's sarcoma associated with acquired immunodeficiency syndrome. J Am Acad Dermatol 1992; 27: 526–530.
- 25
Klein E,
Schwartz RA,
Laor Y,
Milgrom H,
Burgess GH,
Holtermann OA.
Treatment of Kaposi's sarcoma with vinblastine.
Cancer
1980; 45: 427–431.
10.1002/1097-0142(19800201)45:3<427::AID-CNCR2820450304>3.0.CO;2-1 CAS PubMed Web of Science® Google Scholar
- 26
Epstein JB.
Treatment of oral Kaposi sarcoma with intralesional vinblastine.
Cancer
1993; 71:
1722–1725.
10.1002/1097-0142(19930301)71:5<1722::AID-CNCR2820710503>3.0.CO;2-0 CAS PubMed Web of Science® Google Scholar
- 27
Poigronec S,
Lachiver LD,
Lamas G,
Coutellier A,
Caumes E,
Soudant J.
Intralesional Bleomycin for acquired immunodeficiency Syndrome-associated cutaneous Kaposi's sarcoma.
Arch Dermatol
1995; 13: 228.
10.1001/archderm.131.2.228b Google Scholar
- 28 Walmsley S, Northfelt DW, Melosky B, Conant M, Friedman-Kien AE, Wagner B. Treatment of AIDS-related cutaneous Kaposi Sarcoma with topical Alitretinoin (9-cis-retinoic acid) gel. Panretin gel North American Study Group. J Acquir Immune Defic Syndr 1999; 22: 235–246.
- 29 Bodsworth NJ, Bloch M, Bower M, Donnell D, Yocum R. International Panretin gel KS Study Group. Phase III vehicle-controlled multi-centered study of topical alitretinoin gel 0.1% in cutaneous AIDS-related Kaposi's sarcoma. Am J Clin Dermatol 2001; 2: 77–87.
Citing Literature
